Wave life sciences to present at upcoming investor conferences

Cambridge, mass., may 10, 2022 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that paul bolno, md, mba, president and chief executive officer, is scheduled to participate in two upcoming investors conferences in may.
WVE Ratings Summary
WVE Quant Ranking